<p style="text-align:start;" size="0" _root="undefined" __ownerid="undefined" __hash="undefined" __altered="false">To date, Hong Kong-based biotech startup Insilico Medicine has raised more than $360 million, including a Series C funding round of $255 million in June last year. </p>
